19 January 2021 in The Journal of Spinal Cord Medicine
Pre- and post- trial.To determine the changes of health belief levels after a pressure ulcer (PrU) prevention educational program based on the Health Belief Model (HBM)Department of Rehabilitation ...
1 August 2021 in Journal of Multidisciplinary Healthcare
SSSyahiskandar Sybil Shah
Purpose: To collectively identify the clinical characteristics determining the risk of developing spasticity after stroke. Patients and Methods: A cross-sectional study was conducted at a single rehabilitation outpatient clinic from June to December 2019. Inclusion criteria were stroke duration of over four weeks, aged 18 years and above. Exclusion criteria were presence of concurrent conditions other than stroke that could also lead to spasticity. Recruited patients were divided into “Spasticity” and “No spasticity” groups. Univariate analysis was deployed to identify significant predictive spasticity factors between the two groups followed by a two-step clustering approach for determining group of characteristics that collectively contributes to the risk of developing spasticity in the “Spasticity” group. Results: A total of 216 post-stroke participants were recruited. The duration after stroke (p < 0.001) and the absence of hemisensory loss (p = 0.042) were two significant factors in the “Spasticity” group revealed by the univariate analysis. From a total of 98 participants with spasticity, the largest cluster of individuals (40 patients, 40.8%) was those within less than 20 months after stroke with moderate stroke and absence of hemisensory loss, while the smallest cluster was those within less than 20 months after severe stroke and absence of hemisensory loss (21 patients, 21.4%). Conclusion: Analyzing collectively the significant factors of developing spasticity may have the potential to be more clinically relevant in a heterogeneous post-stroke population that may assist in the spasticity management and treatment.
28 July 2021 in Behavioural Neurology
Stroke is one of the most deliberating causes of mortality and disability worldwide. Studies have implicated Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene as a genetic factor influencing stroke recovery. Still, the role of BDNF polymorphism in poststroke aphasia is relatively unclear. This review assesses the recent evidence on the association between the BDNF polymorphism and aphasia recovery in poststroke patients. The article highlights BNDF polymorphism characteristics, speech and language interventions delivered, and the influence of BNDF polymorphism on poststroke aphasia recovery. We conducted a literature search through PubMed and Google Scholar with the following terms: brain derived-neurotrophic factor and aphasia for original articles from January 2000 until June 2020. Out of 69 search results, a detailed selection process produced a total of 3 articles that met the eligibility criteria. All three studies included Val66Met polymorphism as the studied human BDNF gene. One of the studies demonstrated insufficient evidence to conclude that BDNF polymorphism plays a role in poststroke aphasia recovery. The remaining two studies have shown that Met allele genotype (either single or double nucleotides) was associated with poor aphasia recovery, in either acute or chronic stroke. Carriers of the Val66Met polymorphism of BDNF gave a poorer response to aphasia intervention and presented with more severe aphasia.
15 November 2023 in International Journal of Online and Biomedical Engineering (iJOE)
MZMuhammad Firas Zulkifli
Severe hand injuries resulting from accidents can lead to the traumatic loss of an upper limb. The provision of an assistive device, such as an arm prosthesis, can help patients regain their courage and motivation to engage with the public. This project aimed to integrate 3D scanning and printing technology to develop a customized passive arm prosthesis for individuals who have experienced shoulder disarticulation due to a traumatic accident. The fabrication of the arm prosthesis was specifically designed and tailored to meet each patient’s unique needs and preferences. The prosthesis design was created based on 3D scan files obtained from the patients. Finite element analysis was employed to analyze the design and determine the optimal materials to use, as well as to optimize the overall design. The finalized model was then converted into STL file format and G-code for the 3D printing process. To ensure ease of use, the entire arm prosthesis and a harness system were assembled, and multiple tests and fittings were conducted on the patient. Several prototypes of the arm prosthesis were fabricated to achieve the best fit for each individual patient.
23 November 2020 in Spinal Cord